Cargando…
Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications
Angiotensinogen – a serpin family protein predominantly produced by the liver is systematically processed by proteases of the Renin Angiotensin system (RAS) generating hormone peptides. Specific cell surface receptors for at least three distinct angiotensin peptides produce distinct cellular signals...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976824/ https://www.ncbi.nlm.nih.gov/pubmed/27512731 http://dx.doi.org/10.4172/jcs.1000111 |
_version_ | 1782446925749944320 |
---|---|
author | Singh, Khuraijam Dhanachandra Karnik, Sadashiva S |
author_facet | Singh, Khuraijam Dhanachandra Karnik, Sadashiva S |
author_sort | Singh, Khuraijam Dhanachandra |
collection | PubMed |
description | Angiotensinogen – a serpin family protein predominantly produced by the liver is systematically processed by proteases of the Renin Angiotensin system (RAS) generating hormone peptides. Specific cell surface receptors for at least three distinct angiotensin peptides produce distinct cellular signals that regulate system-wide physiological response to RAS. Two well characterized receptors are angiotensin type 1 receptor (AT1 receptor) and type 2 receptor (AT2 receptor). They respond to the octapeptide hormone angiotensin II. The oncogene product MAS is a putative receptor for Ang (1–7). While these are G-protein coupled receptors (GPCRs), the in vivo angiotensin IV binding sites may be type 2 transmembrane proteins. These four receptors together regulate cardiovascular, hemodynamic, neurological, renal, and endothelial functions; as well as cell proliferation, survival, matrix-cell interactions and inflammation. Angiotensin receptors are important therapeutic targets for several diseases. Thus, researchers and pharmaceutical companies are focusing on drugs targeting AT1 receptor than AT2 receptor, MAS and AngIV binding sites. AT1 receptor blockers are the cornerstone of current treatment for hypertension, heart failure, renal failure and many types of vascular diseases including atherosclerosis, aortic aneurism and Marfan syndrome. |
format | Online Article Text |
id | pubmed-4976824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-49768242016-08-08 Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications Singh, Khuraijam Dhanachandra Karnik, Sadashiva S J Cell Signal Article Angiotensinogen – a serpin family protein predominantly produced by the liver is systematically processed by proteases of the Renin Angiotensin system (RAS) generating hormone peptides. Specific cell surface receptors for at least three distinct angiotensin peptides produce distinct cellular signals that regulate system-wide physiological response to RAS. Two well characterized receptors are angiotensin type 1 receptor (AT1 receptor) and type 2 receptor (AT2 receptor). They respond to the octapeptide hormone angiotensin II. The oncogene product MAS is a putative receptor for Ang (1–7). While these are G-protein coupled receptors (GPCRs), the in vivo angiotensin IV binding sites may be type 2 transmembrane proteins. These four receptors together regulate cardiovascular, hemodynamic, neurological, renal, and endothelial functions; as well as cell proliferation, survival, matrix-cell interactions and inflammation. Angiotensin receptors are important therapeutic targets for several diseases. Thus, researchers and pharmaceutical companies are focusing on drugs targeting AT1 receptor than AT2 receptor, MAS and AngIV binding sites. AT1 receptor blockers are the cornerstone of current treatment for hypertension, heart failure, renal failure and many types of vascular diseases including atherosclerosis, aortic aneurism and Marfan syndrome. 2016-04-08 2016-06 /pmc/articles/PMC4976824/ /pubmed/27512731 http://dx.doi.org/10.4172/jcs.1000111 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Singh, Khuraijam Dhanachandra Karnik, Sadashiva S Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title_full | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title_fullStr | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title_full_unstemmed | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title_short | Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications |
title_sort | angiotensin receptors: structure, function, signaling and clinical applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976824/ https://www.ncbi.nlm.nih.gov/pubmed/27512731 http://dx.doi.org/10.4172/jcs.1000111 |
work_keys_str_mv | AT singhkhuraijamdhanachandra angiotensinreceptorsstructurefunctionsignalingandclinicalapplications AT karniksadashivas angiotensinreceptorsstructurefunctionsignalingandclinicalapplications |